AMGN vs GILD Stock Comparison

AMGN

Amgen Inc.

$345.73

GILD

Gilead Sciences, Inc.

$128.10

Head-to-Head Comparison

Metric	AMGN	GILD
Market Cap	$155.0B	$115.0B
P/E Ratio	16.0	14.0
Div Yield	N/A	N/A
Sector	Healthcare	Healthcare
Beta	0.42	0.33
Revenue	N/A	N/A
Net Income	N/A	N/A
EPS	N/A	N/A

AI Comparison Brief

AI Generated

Verdict

Gilead Sciences, Inc. (GILD) presents a more attractive investment opportunity compared to Amgen Inc. (AMGN) at this time. With a lower stock price and a slightly more favorable beta, GILD appears less volatile and offers a better risk/reward profile. Although both companies lack current P/E ratios and dividend yields, GILD's position in the market suggests a potentially stronger growth trajectory in the pharmaceutical sector.

Key Differences

Business Model: Amgen focuses heavily on biotechnology and has a diverse portfolio of biologic therapies, while Gilead specializes in antiviral drugs, especially for HIV and Hepatitis C, providing a different market niche.
Valuation Metrics: Neither company currently provides P/E or EPS data, highlighting a lack of immediate valuation clarity; however, GILD's lower price may suggest a more attractive entry point for investors.
Growth Potential: GILD is positioned for growth with its innovative therapies and strategic acquisitions, while AMGN's growth may be more stagnant due to its reliance on established products.
Risk Profile: GILD's lower beta (0.331) compared to AMGN’s (0.416) indicates that GILD may experience less price volatility, making it a safer investment choice.

Bottom Line

Investors seeking stability and growth potential should consider Gilead Sciences, Inc. (GILD) over Amgen Inc. (AMGN). GILD is better suited for those looking for a lower-risk investment with promising future prospects in the healthcare sector.

This comparison is AI-generated using publicly available market data and is for informational purposes only. It does not constitute investment advice. Always conduct your own research before making investment decisions.

Analysis generated 2026-06-16

Price Chart — AMGN vs GILD

Loading chart...

→ Amgen Inc. (AMGN) Full Analysis → Gilead Sciences, Inc. (GILD) Full Analysis ← Stock Screener

Disclaimer: Stock data sourced from Financial Modeling Prep, updated daily. Prices may be delayed. Interactive charts powered by TradingView. This page is for informational and educational purposes only and does not constitute investment advice. We are not licensed financial advisors. Please consult a qualified professional before making investment decisions.

Privacy Policy · Terms